
Adipogen/Ciglitazone/AG-CR1-0033-M025/25 mg
商品编号:
AG-CR1-0033-M025
品牌:
Adipogen Inc
市场价:
¥6400.00
美元价:
3840.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
ProductDetails | |
---|---|
Synonyms | (±)-5-[4-(1-Methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione;U-63287 |
ProductType | Chemical |
Properties | |
Formula | C18H23NO3S |
MW | 333.5 |
CAS | 74772-77-3 |
RTECS | XJ5813700 |
PurityChemicals | ≥99%(NMR) |
Appearance | Off-whitesolid. |
Solubility | SolubleinDMSOor100%ethanol. |
OtherProductData | Stocksolutionsarestableforupto3monthswhenstoredat-20°C. |
InChiKey | YZFWTZACSRHJQD-UHFFFAOYSA-N |
ShippingandHandling | |
Shipping | AMBIENT |
ShortTermStorage | +4°C |
LongTermStorage | +4°C |
Use/StABIlity | Stableforatleast2yearsafterreceiptwhenstoredat+4°C. |
Documents | |
MSDS | ![]() |
ProductSpecificationSheet | |
Datasheet | ![]() |
- SelectivePPARγagoNIST(EC50=3µM)[1].
- Hypoglycemicagent[2,3].
- Angiogenesisinhibitor[4].
- Anti-inflammatory[5].
- Apoptosisinducer[6].
ProductReferences
- Thestructure-activityrelationshipbetweenperoxisomeproliferator-activatedreceptorgammaagonismandtheantihyperglycemicactivityofthiazolidinediones:T.M.Willson,etal.;J.Med.Chem. 39,665(1996)
- Reductionofinsulinresistanceinobeseand/ordiabeticanimalsby5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione(ADD-3878,U-63,287,ciglitazone),anewantidiabeticagent:T.Fujita,etal.;Diabetes32,804(1983)
- [[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinedionesaspotentantihyperglycemicagents:B.C.Cantello,etal.;J.Med.Chem. 37,3977(1994)
- Peroxisomeproliferator-activatedreceptorgammaligandsarepotentinhibitorsofangiogenesisinvitroandinvivo:X.Xin,etal.;J.Biol.Chem. 274,9116(1999)
- ThethiazolidinedioneciglitazonereducesbacterialoutgrowthandearlyinflammationduringStreptococcuspneumoniaepneumoniainmice:M.E.Stegenga,etal.;Crit.CareMed.37,614(2009)
- Ciglitazone,anovelinhibitoroflungapoptosisfollowinghemorrhagicshock:R.S.Chima,etal.;Int.J.Clin.Exp.Med.3,1(2010)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们